Answers are grounded in this paper and cite their sources.
Case report identifies rhabdomyolysis from atorvastatin in a woman with coronary artery disease, suggesting serious risks.
The extreme form of statin-related muscle involvement leading to rhabdomyolysis is not uncommon. We, in this case report, present a patient with rhabdomyolysis following high-dose atorvastatin treatment. The patient was a 60-year-old female with a background of coronary artery disease and acute coronary syndrome, who was subjected to percutaneous coronary intervention and stenting 2 months back and was then put on high-intensity statin (atorvastatin 80 mg daily) and other guideline-recommended drugs. She presented with severe generalized body aches, fatigue, and marked weakness in the proximal muscles of her limbs and acute renal shutdown. She was diagnosed to be a case of statin-induced rhabdomyolysis on the basis of an extremely high creatine phosphokinase level of 36,210 units/L. Despite fluid and electrolyte management and alternate-day hemodialysis, the patient's renal parameters did not improve, and she succumbed on day 15 of hospitalization.
No takes yet. Share an insight, caveat, or question.
Behera et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: